Health ❯Healthcare ❯Pharmaceuticals

Drug Pricing

Medicare Prescription Drugs Medicare Negotiations Weight Loss Drugs Market Competition Medicare Negotiation Market Regulation Weight Loss Medications Medicare and Medicaid Generic Drugs

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

U.S. Drug Launch Prices Skyrocket, Driven by Rare Disease Treatments

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Merck Cuts 2025 Revenue Forecast, Pushes Ahead with US Expansion

Trump’s Executive Order Targets Prescription Drug Prices and PBMs

Trump’s Executive Order Targets U.S. Drug Prices with Foreign Rate Parity

Trump Signs Decree to Slash U.S. Drug Prices by Up to 80%

Trump Signs Sweeping Order to Cap U.S. Drug Prices at Global Lows

Trump Signs Executive Order to Slash U.S. Drug Prices by Up to 80%

Indian Pharma Stocks Decline as Trump Announces Major Drug Price Cuts

Trump to Revive Medicare Drug Pricing Plan via Executive Order

Trump Administration NIH Cuts Terminate $1.81 Billion in Research Funding

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

Pharmaceutical Giants Grapple With Tariff Uncertainty as Roche Seeks Exemptions

Trump Administration Weighs Pilot to Tie U.S. Drug Prices to Global Benchmarks

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Jon Stewart and Elon Musk Set Stage for Unedited 'Daily Show' Interview

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

U.S. Store Closures Predicted to Hit 15,000 in 2025, Doubling Last Year’s Total